Get the Stockscreener App
10.65
2.07%
-0.225
After Hours:
10.05
-0.605
-5.68%
Avalo Therapeutics Inc stock is traded at $10.65, with a volume of 115.85K.
It is down -2.07% in the last 24 hours and up +13.84% over the past month.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
See More
Previous Close:
$10.88
Open:
$10.88
24h Volume:
115.85K
Relative Volume:
0.61
Market Cap:
$140.14M
Revenue:
$1.93M
Net Income/Loss:
$-7.96M
P/E Ratio:
-0.00302
EPS:
-3530.8178
Net Cash Flow:
$-36.78M
1W Performance:
-8.15%
1M Performance:
+13.84%
6M Performance:
+38.38%
1Y Performance:
+18.52%
1-Day Range:
$10.55
$11.33
1-Week Range:
$10.55
$12.11
52-Week Range:
$3.39
$16.00
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Name
Avalo Therapeutics Inc
Sector
Industry
Phone
410-522-8707
Address
1500 LIBERTY RIDGE DRIVE, WAYNE
Compare AVTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
10.65 | 144.94M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-05-25 | Initiated | TD Cowen | Buy |
| Aug-15-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-02-25 | Resumed | H.C. Wainwright | Buy |
| Mar-25-25 | Initiated | Jefferies | Buy |
| Mar-25-25 | Initiated | Stifel | Buy |
| Feb-28-25 | Initiated | Piper Sandler | Overweight |
| Feb-21-25 | Initiated | Wedbush | Outperform |
| Dec-19-24 | Initiated | BTIG Research | Buy |
| Oct-24-24 | Initiated | H.C. Wainwright | Neutral |
| Apr-16-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-24-21 | Initiated | RBC Capital Mkts | Outperform |
View All
Avalo Therapeutics Inc Stock (AVTX) Latest News
Will Avalo Therapeutics Inc. outperform the marketMarket Sentiment Report & AI Forecast Swing Trade Picks - Newser
Sector ETF performance correlation with Avalo Therapeutics Inc.Quarterly Earnings Report & Weekly Market Pulse Updates - Newser
Historical volatility pattern of Avalo Therapeutics Inc. visualizedJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - Newser
How to build a custom watchlist for Avalo Therapeutics Inc.July 2025 Trade Ideas & AI Based Buy and Sell Signals - Newser
What technical models suggest about Avalo Therapeutics Inc.’s comeback - Newser
Volatility clustering patterns for Avalo Therapeutics Inc.Market Performance Recap & Technical Confirmation Trade Alerts - Newser
Will Avalo Therapeutics Inc. benefit from macro trendsM&A Rumor & Consistent Growth Stock Picks - Newser
How to use Fibonacci retracement on Avalo Therapeutics Inc.Quarterly Market Review & Accurate Buy Signal Notifications - Newser
Avalo Therapeutics Inc. stock momentum explainedInsider Buying & Weekly Market Pulse Alerts - Newser
Understanding Avalo Therapeutics Inc.’s price movementRate Hike & AI Driven Stock Reports - Newser
What indicators show strength in Avalo Therapeutics Inc.2025 Geopolitical Influence & Capital Protection Trading Alerts - Newser
Is it too late to sell Avalo Therapeutics Inc.Volume Spike & Weekly Chart Analysis and Trade Guides - Newser
understanding avalo therapeutics inc.’s price movementRate Cut & Verified Momentum Watchlists - Newser
Advanced analytics toolkit walkthrough for Avalo Therapeutics Inc.July 2025 Opening Moves & Daily Momentum Trading Reports - Newser
Candlestick signals on Avalo Therapeutics Inc. stock today2025 Price Momentum & Daily Market Momentum Tracking - Newser
Published on: 2025-09-12 02:08:30 - Newser
Using Bollinger Bands to evaluate Avalo Therapeutics Inc.Weekly Gains Report & Verified Swing Trading Watchlist - Newser
Using data models to predict Avalo Therapeutics Inc. stock movementJobs Report & High Win Rate Trade Alerts - Newser
Avalo Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - Newser
News impact scoring models applied to Avalo Therapeutics Inc.2025 Earnings Surprises & Stepwise Trade Signal Guides - Newser
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Sees Large Increase in Short Interest - MarketBeat
Should you hold or exit Avalo Therapeutics Inc. nowMarket Risk Summary & Daily Market Momentum Tracking - Newser
what technical models suggest about avalo therapeutics inc.’s comeback - Newser
What makes Vivos Therapeutics, Inc. stock price move sharply - Newser
Real time scanner hits for Avalo Therapeutics Inc. explainedMarket Risk Report & Free High Accuracy Swing Entry Alerts - Newser
Can swing trading help recover from Avalo Therapeutics Inc. lossesJuly 2025 Momentum & Free High Return Stock Watch Alerts - Newser
How institutional ownership impacts Avalo Therapeutics Inc. stockJuly 2025 Market Mood & Target Return Focused Picks - Newser
Avalo Therapeutics, Inc. $AVTX Stock Position Raised by Allostery Investments LP - MarketBeat
Avalo Therapeutics Inc Stock (AVTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):